In future work, it will be interesting to determine in HHT models whether VE-cadherin proteolytic processing accompanies vascular lesion development and is a consequence of reduced BMP9/10-ALK1-ENG signaling, as suggested by our in vitro studies. The gene discussed is ACVRL1; the disease is hereditary hemorrhagic telangiectasia.